Monitor.
Detect.
Alert.

Critical neurovascular events
—including stroke—
are detected too late.


Avertto redefines the standard of care through carotid biological mimicry—turning the neck into a real-time window for early detection
before neurological damage occurs.

Mission

Giving clinicians the gift of time—using carotid biological mimicry to detect critical hemodynamic changes before irreversible damage.

monitor

AMIT301 continuously monitors pressure waveform hemodynamic features.

Detect

Avertto’s algorithm detects pressure asymmetry in real time.

alert

AMIT301 identifies hemodynamic risks for clinical decision support.

WINDOW OF OPPORTUNITY

Therapeutic window for thrombectomy is 6 hours

AMIT 301 - our first commercial device | fda class 1

SUCCESSFUL CLINICAL RESULTS

Early Detection of Large Vessel Occlusions by Bilateral Carotid Pressure Monitoring:
Blinded Observational Study

100% sensitivity, 86% specificity- using passive bilateral carotid sensors.

Alerts within the therapeutic window — when imaging and thrombectomy were still an option

Neurological deterioration was associated with pronounced asymmetry

Severe MCA stroke led to death after 11 months; estimated costs $300K–$675K

NEWS AND publications

Avertto Updates

Publications

OUR values

Avertto Management Code - inspired by Amit Man

Saving Lives: Purpose. Urgency. Compassion. Responsibility. Impact.
Ecosystem Catalyst:
Resilience. Collaboration. Contribution. Partnership. Legacy.
Zero Workflow Education:
Simplicity. Practicality. Adaptability. Usability. Integration.
Lean & Efficient:
Focus. Discipline. Clarity. Resourcefulness. Excellence.
Act Now:
Decisiveness. Momentum. Courage. Ownership. Execution.

A SEASONED TEAM

Experts in medical devices, clinical trials, and global business development.

Dr. Hilla Ben-Pazi
MD, Neurologist
Founder & CEO
A senior neurologist with over two decades of experience in clinical studies and collaborative networks,  founder and owner of the first tele-neurology company in Israel (2017, NeuroCan). Winner of EIC WomenTech leadership program.
Asher Kuper
BSc. BioMedicine,  MBA, CTO
Over 20 years of experience in the MedTech industry, serving in executive roles including VP R&D at Bluewind Medical, CEO of spirCare, VP Product and VP Medical Device at Zebra Medical Vision, and senior leadership positions at GE Healthcare and Aspect Imaging.
Kety Bardugo
BA., ICQE,
Chief Quality & Regulatory Officer
A Quality and Regulatory Affairs expert with 20+ years in the medical device field. Kety specializes in scaling quality frameworks for startups and global firms, guiding products from R&D to market. She leads strategic collaborations with regulatory authorities and notified bodies throughout the entire product lifecycle.
Yair Lavi
BSc.,MSc., Physics
Algo team leader
Leader of Avertto’s Algo Team, is an experienced algorithms developer and manager with expertise in AI, deep learning, and signal processing on time series data, and has contributed to the success of startups like Tonara, 3DSignals, and Sosense.
Meron Ben Pazi
BA, Physics
Product Manager

Meron is a Product Manager with a practical technical background and hands-on R&D experience. He leads requirements, prioritization, and cross-functional delivery while aligning product goals with engineering constraints. He brings expertise in mechanical and electrical systems.

Lior Elmaliach
BA, Biology
Clinical team
Clinical assistant at Avertto with a biology degree from Tel Aviv University. She supports clinical site engagement, ensures timely and accurate completion of eCRFs, and addresses issues as they arise. She works closely with site research coordinators, building strong relationships to ensure smooth and efficient clinical trial operations.

Avertto commemorates Amit Man, a paramedic killed at Kibbutz Be'eri on October 7th, 2023, at just 22 years old. Amit's path into medicine began at age 10, when her father was diagnosed with cancer. By 18, she was a certified paramedic — balancing her calling in medicine with a parallel life as an actor, model, and singer.
On October 7th, Amit chose to stay. Knowing she was needed, she provided lifesaving care under fire for seven hours, with extraordinary courage and compassion, until she was killed.
As part of the Next October commemoration initiative, Avertto embraces Amit's legacy: a relentless dedication to saving lives. Her courage, leadership, and unwavering commitment to others in the face of danger inspire everything we do — and remind us that in matters of health and human life, every moment counts.

WE WOULD BE HAPPY TO HEAR FROM YOU

Dedicated to improving healthcare and patient outcome, please contact us for further information by completing your details below. Our expert team member will contact you shortly

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.